background study previously showed cystic fibrosis deletion deltaf508 heterozygosity overrepresented individuals asthma objective using followup data copenhagen city heart study explore relationship methods NUMBER surveys NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER measured pulmonary function asked participants asthma pulmonary risk factors results difference annual decline lung function deltaf508 heterozygotes noncarriers overall individuals familial asthma annual declines fev1 forced vital capacity fvc NUMBER NUMBER ml deltaf508 heterozygotes versus NUMBER NUMBER ml noncarriers p NUMBER p NUMBER respectively based triple measurements fev1 fvc individuals aged NUMBER NUMBER years lower heterozygous participants versus noncarriers p NUMBER p NUMBER respectively average reduction fev1 fvc deltaf508 heterozygotes versus noncarriers NUMBER ml p NUMBER NUMBER ml p NUMBER finally NUMBER carriers reported asthma versus NUMBER noncarriers p NUMBER resulting odds ratio NUMBER asthma deltaf508 heterozygotes conclusion cystic fibrosis deltaf508 heterozygotes overrepresented individuals asthma poorer lung function noncarriers furthermore deltaf508 heterozygosity context familial predisposition asthma associated greater annual fev1 decline cross sectional phenylalanine NUMBER NUMBER year cross sectionally NUMBER NUMBER